Physician profile
Benjamin D Kies
NPI 1356859359
$2,364.59
in general payments reported to CMS, 2019-2025
12 companies · $644 in 2025
The $644 reported for 2025 was more than what 76% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $154 · 2022: $637 · 2023: $345 · 2024: $583 · 2025: $644.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,573.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,573.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $494.79 | 2022-2024 | |
| Boston Scientific Corporation | $420.49 | 2024-2025 | Farapulse, Watchman Flx |
| Medtronic, INC. | $405.99 | 2021-2025 | Micra, Na, Linq II |
| Abbott Laboratories | $329.67 | 2022-2025 | Aveir, Ensite, Tacticath Ablation Catheter, Sensor Enabled |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $302.28 | 2021-2025 | Lifevest |
| Biosense Webster, INC. | $99.13 | 2023-2025 | Carto 3 |
| Impulse Dynamics (USA) INC. | $89.27 | 2024 | Optimizer |
| Janssen Pharmaceuticals, INC | $83.43 | 2022-2024 | Xarelto |
| Abiomed | $66.79 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $40.85 | 2024-2025 | Camzyos, Eliquis |
| Cardiva Medical, INC. | $16.29 | 2025 | Cardiva Vascade Mvp Xl Vvcs 10-12f |
| Novo Nordisk INC | $15.61 | 2024 | Ozempic, Rybelsus |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Kies listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.